Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Neogen Chemicals's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 2,901.87 | 1,747.31 | 1,461.4 |
| Accumulated Depreciation Total | -91.95 | -69.89 | -64.15 |
| Other Liabilities Total | 17.85 | 13.2 | 12.73 |
| Accrued Expenses | 21.07 | 13.07 | 9.01 |
| Long Term Debt | 819.15 | 170.1 | 124.23 |
| Common Stock Total | 26.38 | 26.38 | 26.38 |
| Other Equity Total | -0.27 | -1.04 | -0.6 |
| Other Current Assets Total | 14.44 | 28.8 | 3.03 |
| Prepaid Expenses | 24.6 | 8.31 | 2.71 |
| Total Assets | 2,901.87 | 1,747.31 | 1,461.4 |
| Current Portof LT Debt/Capital Leases | 45.18 | 50.61 | 28.74 |
| Additional Paid-In Capital | 521.98 | 521.98 | 521.98 |
| Cash | 4.94 | 4.96 | 12.23 |
| Total Equity | 816.25 | 789.39 | 760.29 |
| Long Term Investments | 0.45 | 0.45 | 0.45 |
| Retained Earnings(Accumulated Deficit) | 268.95 | 242.07 | 212.53 |
| Treasury Stock-Common | -0.79 | Not available | Not available |
| Total Common Shares Outstanding | 2.64 | 2.64 | 2.64 |
| Property/Plant/Equipment Total-Gross | 1,423.24 | 627.29 | 667.55 |
| Tangible Book Valueper Share Common Eq | 309.22 | 298.86 | 287.75 |
| Total Liabilities | 2,085.62 | 957.92 | 701.11 |
| Total Debt | 1,395.09 | 596.74 | 408.92 |
| Cashand Short Term Investments | 4.94 | 4.97 | 12.52 |
| Total Receivables Net | 763.84 | 643 | 377.92 |
| Notes Payable/Short Term Debt | 481.83 | 352.22 | 242.5 |
| Deferred Income Tax | 12.02 | 17.41 | 23.73 |
| Accounts Receivable-Trade Net | 448.14 | 262.05 | 348.46 |
| Property/Plant/Equipment Total-Net | 1,331.28 | 559.1 | 603.38 |
| Total Current Liabilities | 1,187.67 | 733.4 | 526.97 |
| Total Inventory | 584.69 | 314.75 | 387.48 |
| Accounts Payable | 442.14 | 263.19 | 144.6 |
| Other Currentliabilities Total | 197.45 | 54.31 | 102.12 |
| Total Long Term Debt | 868.08 | 193.91 | 137.68 |
| Intangibles Net | 0.64 | 0.94 | 1.15 |
| Other Long Term Assets Total | 38.79 | 20.27 | 14 |
| Note Receivable-Long Term | 138.2 | 166.72 | 58.76 |
| Total Current Assets | 1,392.51 | 999.83 | 783.66 |
| Capital Lease Obligations | 48.93 | 23.81 | 13.45 |
| Short Term Investments | Not available | 0.01 | 0.29 |
Debt 5Yr CAGR %44.46
Operating Margin 12m13.41
Operating Margin 5y Avg13.18
Net Profit Margin 12m3.85
Net Profit Margin 5y5.53
Dividend Yield %0.05
Price to Sale Ratio6.44
Overall RiskHigh risk
Board Risk51.7
ConsensusBuy
Consensus score2.20
Analyst opinions10
Strong Sell count1
Sell count0
Hold count2
Buy count4
Strong Buy count3
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,749 | 2.64 L | 58.09 | — |
| Solar Industries India | INR 18,560 | 1.68 L | 99.61 | — |
| Pidilite Industries | INR 1,671 | 1.70 L | 64.76 | — |
| SRF | INR 2,626 | 77,841.16 | 44.57 | — |
| Linde India | INR 7,105 | 61,033.66 | 110.53 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Neogen Chemicals Schedules Q1 Earnings Call On July 27 At 4 PM Sahi
Neogen Chemicals to discuss Q1FY27 results on July 27 scanx.trade
Neogen Chemicals Credit Rating Downgraded by CRISIL; Outlook Negative Whalesbook
Neogen Chemicals gets ₹15 crore insurance payout for Dahej fire; total claim reaches ₹155 crore CNBC TV18
Neogen Chemicals Receives ₹15 Crore Payout, Net Impact ₹13.56 Cr After Fire Whalesbook
Neogen Chemicals Ltd Hits Intraday Low Amid Price Pressure on 17 Jul 2026 MarketsMojo
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Neogen Chemicals Limited is an India-based company, which is engaged in the business of manufacturing of specialty chemicals. It is also engaged in manufacturing bromine compounds, lithium-based chemical compounds, advanced intermediates, and custom synthesis and contract manufacturing. Its product category includes organic chemicals, inorganic chemicals, grignard reagents, advance intermediates, and chemistries. Its organic chemicals include organo lithium compounds, specialty chloro compounds, and organo bromine compounds. Its inorganic chemicals include lithium salts. Its advance intermediates include valine methyl ester, 4-bromobutyl acetate, and others. It focuses on producing a wide range of specialty chemicals, including organic and inorganic chemicals. These chemicals are utilized in various industries, such as pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, and specialty polymers.
Neogen Chemicals has the symbol NEOGEN and ISIN - INE136S01016.
Neogen Chemicals is currently trading at INR 2,302.00.
Neogen Chemicals has a year high of INR 2,483.90 and a year low of INR 966.70.
Neogen Chemicals has a market capitalization of INR 5,550.77 crore.
Neogen Chemicals has a P/E ratio of 152.29.
Neogen Chemicals has a dividend yield of 0.05%.
Neogen Chemicals has revenue of INR 861.96 crore, net income of INR 28.75 crore, and EPS of INR 13.30.
Neogen Chemicals has a book value of NA.
Neogen Chemicals has a debt-to-equity ratio of NA.
Neogen Chemicals has a price-to-book ratio of NA and a price-to-sales ratio of 6.44.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.